HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
Clinical trial NCT03934736 · COMPLETED
Trial details
- NCT number
- NCT03934736
- Sponsor
- Dynavax Technologies Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2020-10-23
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.